Related Experiment Video

Updated: Sep 3, 2026

Isolation of Human Monocytes by Double Gradient Centrifugation and Their Differentiation to Macrophages in Teflon-coated Cell Culture Bags
09:32

Isolation of Human Monocytes by Double Gradient Centrifugation and Their Differentiation to Macrophages in Teflon-coated Cell Culture Bags

Published on: September 9, 2014

Human recombinant macrophage colony-stimulating factor (M-CSF) increases Cl-esterase inhibitor (Cl-INH) synthesis by

B Schmidt1, G Gyapay, M Válay

  • 1Department of Immunopathology, National Institute of Hematology and Blood Transfusion, Budapest, Hungary.

Immunology
|December 1, 1991
PubMed

Insights

Macrophage colony-stimulating factor (M-CSF) selectively increases complement protein Cl-esterase inhibitor (Cl-INH) production in human monocytes. M-CSF did not significantly alter factor B or C2 levels in this study.

Area of Science:

  • Immunology
  • Cell Biology
  • Complement System

Background:

  • Human monocytes are key immune cells involved in innate immunity.
  • The complement system is a crucial part of the immune system, involving numerous protein factors.
  • Macrophage colony-stimulating factor (M-CSF) is a cytokine that regulates the development and function of monocytes and macrophages.

Purpose of the Study:

  • To investigate the effect of M-CSF on the production of specific complement proteins by human monocytes.
  • To determine if M-CSF influences the synthesis of factor B, C2, and Cl-esterase inhibitor (Cl-INH).

Main Methods:

  • Cultured human monocytes were treated with varying concentrations of recombinant human M-CSF.
  • Complement protein levels (factor B, C2, Cl-INH) were measured using ELISA and immunohaemolytic assays.
  • Monocytes were cultured for a total of 6 days, with M-CSF treatment for the initial 3 days.

Main Results:

  • M-CSF treatment resulted in a dose-dependent increase in the synthesis of Cl-esterase inhibitor (Cl-INH).
  • M-CSF did not significantly affect the production of factor B (Bf) or C2.
  • The observed changes in Cl-INH were sustained for at least 3 days after M-CSF removal.

Conclusions:

  • M-CSF selectively modulates the production of complement proteins by human monocytes.
  • M-CSF enhances the synthesis of Cl-esterase inhibitor, suggesting a role in regulating complement activity.
  • These findings highlight a specific mechanism by which M-CSF influences monocyte immunomodulatory functions.

More Related Videos

Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages06:46

Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages

Published on: June 30, 2016

Isolation, Transfection, and Culture of Primary Human Monocytes09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...